Questions About Cancer? 1-800-4-CANCER

All News Releases

TCGA researchers identify four subtypes of stomach cancer
NCI Press Release
(Posted: 07/23/2014) - Stomach cancers fall into four distinct molecular subtypes, researchers with The Cancer Genome Atlas (TCGA) Network have found. Scientists report that this discovery could change how researchers think about developing treatments for stomach cancer, also called gastric cancers or gastric adenocarcinomas.

Penn Medicine researchers find that a metabolic enzyme stops progression of most common type of kidney cancer
NCI Cancer Center News
(Posted: 07/21/2014) - Researchers found that an enzyme called FBP1 -- essential for regulating metabolism -- binds to a transcription factor in the nucleus of certain kidney cells and restrains energy production in the cell body.

Researchers report first large-scale integrated proteomic and genomic analysis of a human cancer: Identification of new molecular features of colorectal cancer
NCI News Note
(Posted: 07/21/2014) - Investigators who analyzed 95 human colorectal tumor samples have determined how gene alterations identified in previous analyses of the same samples are expressed at the protein level. The integration of proteomic and genomic data, or proteogenomics, provides a more comprehensive view of the biological features that drive cancer than genomic analysis alone.

Salk scientists identify a new gene that could stop the spread of deadly cancer
NCI Cancer Center News
(Posted: 07/18/2014) - Scientists at the Salk Institute have identified a gene responsible for stopping the movement of cancer from the lungs to other parts of the body, indicating a new way to fight one of the world's deadliest cancers.

NIH study finds negative HPV screening test result is a better predictor of low cervical cancer risk than a negative Pap test
NCI Press Release
(Posted: 07/18/2014) - Based on a study that included more than 1 million women, investigators at NCI have determined that a negative test for HPV infection compared to a negative Pap test provides greater safety, or assurance, against future risk of cervical cancer.
View the article in Spanish

Multi-institute research on prostate cancer is focus of 2 studies, commentary
NCI Cancer Center News
(Posted: 07/15/2014) - Management of low-risk prostate cancer varies widely among urologists and radiation oncologists, with patients whose diagnosis is made by a urologist that treats non-low-risk prostate cancer more likely to receive treatment vs. observation.

UC Davis researchers find that a new combination drug controls tumor growth and metastasis in mice
NCI Cancer Center News
(Posted: 07/15/2014) - Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and metastasis in mice.

UCLA study finds that depressed men with prostate cancer are diagnosed with later stage disease, and get less effective therapies
NCI Cancer Center News
(Posted: 07/14/2014) - Although demographic and socioeconomic differences can affect treatment and outcomes in prostate cancer, the effect of mental health disorders has remained unclear.

Dana-Farber researchers find that antibody in mice halts cancer-related wasting condition
NCI Cancer Center News
(Posted: 07/14/2014) - Dana-Farber scientists identify a protein that is a cause of cachexia, a severe wasting of fat and muscle in half of all cancer patients, and show that blocking the protein in mice can prevent or halt the debilitating condition.

Stanford researchers create tool to help unravel some secrets of cancer
NCI Cancer Center News
(Posted: 07/11/2014) - Using novel methods, scientists have identified biological signatures in cancer cells that can be traced back to the original cancer gene.

< Previous  19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39  Next >